Advertisement

International Journal of Clinical Pharmacy

, Volume 34, Issue 4, pp 506–509 | Cite as

WHO guidelines for treatment of tuberculosis: the missing links

  • Muhammad AtifEmail author
  • Syed Azhar Syed Sulaiman
  • Asrul Akmal Shafie
  • Irfhan Ali
  • Mohamed Azmi Hassali
  • Fahad Saleem
Commentary

Abstract

Worldwide, the treatment of tuberculosis is based on evidence-based guidelines developed by the World Health Organization (WHO) for national tuberculosis programs. However, the importance of health related quality of life, the adequate management of side effects associated with antituberculosis drugs and the elaboration of tuberculosis treatment outcome categories are a few issues that need to be addressed in forthcoming WHO guidelines for the treatment of tuberculosis.

Keywords

Antihistamines Health related quality of life Side effects Sputum induction Treatment outcomes Tuberculosis WHO Guidelines 

Notes

Funding

Authors would like to thank Institute of Postgraduate Studies (IPS) at University Sains Malaysia for their financial support in carrying out this work through USM-RU-PRGS (1001/PFARMASI/844011).

Conflicts of interest

None.

References

  1. 1.
    World Health Organization. Treatment of Tuberculosis Guidelines; 2009. Report No.: WHO/HTM/TB/2009/420. ISBN: 9789241547833.Google Scholar
  2. 2.
    World Health Organization. Preamble to the constitution of the World Health Organization as adopted by the International Health Conference. International Health Conference; New York. 1946 [cited 1 May 2012]; Available from: http://whqlibdoc.who.int/hist/official_records/constitution.pdf.
  3. 3.
    Spilker B. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven Philadelphia; 1996. ISBN: 0781703328.Google Scholar
  4. 4.
    Rajeswari R, Muniyandi M, Balasubramanian R, Narayanan PR. Perceptions of tuberculosis patients about their physical, mental and social well-being: a field report from south India. Soc Sci Med. 2005;60(8):1845–53.PubMedCrossRefGoogle Scholar
  5. 5.
    Sherbourne CD, Sturm R, Wells KB. What outcomes matter to patients? J Gen Intern Med. 1999;14(6):357–63.PubMedCrossRefGoogle Scholar
  6. 6.
    Marra CA, Marra F, Cox VC, Palepu A, Fitzgerald JM. Factors influencing quality of life in patients with active tuberculosis. Health Qual Life Outcomes. 2004;2(1):58.PubMedCrossRefGoogle Scholar
  7. 7.
    Hansel NN, Wu AW, Chang B, Diette GB. Quality of life in tuberculosis: patient and provider perspectives. Qual Life Res. 2004;13(3):639–52.PubMedCrossRefGoogle Scholar
  8. 8.
    Macq J, Solis A, Martinez G, Martiny P, Dujardin B. An exploration of the social stigma of tuberculosis in five. Health Policy. 2005;74(2):205–17.PubMedCrossRefGoogle Scholar
  9. 9.
    Guo N, Marra F, Marra CA. Measuring health-related quality of life in tuberculosis: a systematic. Health Qual Life Outcomes. 2009;7:14.PubMedCrossRefGoogle Scholar
  10. 10.
    Dhuria M, Sharma N, Ingle GK. Impact of tuberculosis on the quality of life. Indian J Commun Med. 2008;33(1):58–9.CrossRefGoogle Scholar
  11. 11.
    Dhingra VK, Rajpal S. Health related quality of life (HRQL) scoring (DR-12 score) in tuberculosis–additional evaluative tool under DOTS. J Commun Dis. 2005;37(4):261–8.PubMedGoogle Scholar
  12. 12.
    Li LM, Bai LQ, Yang HL, Xiao CF, Tang RY, Chen YF, et al. Sputum induction to improve the diagnostic yield in patients with suspected pulmonary tuberculosis notes from the field. Int J Tuberc Lung Dis. 1999;3(12):1137–9.PubMedGoogle Scholar
  13. 13.
    Parry CM, Kamoto O, Harries AD, Wirima JJ, Nyirenda CM, Nyangulu DS, et al. The use of sputum induction for establishing a diagnosis in patients with suspected pulmonary tuberculosis in Malawi. Tuber Lung Dis. 1995;6(1):72–6.CrossRefGoogle Scholar
  14. 14.
    Leigh TR, Hume C, Gazzard B, Parsons P, Husain OAN, Collins JV. Sputum induction for diagnosis of Pneumocystis carinii pneumonia. Lancet. 1989;334(8656):205–6.CrossRefGoogle Scholar
  15. 15.
    Shata AM, Coulter JB, Parry CM, Ching’ani G, Broadhead RL, Hart CA. Sputum induction for the diagnosis of tuberculosis. Arch Dis Child. 1996;74(6):535–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Wills PJ, Hall RL, Chan W, Cole PJ. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J Clin Invest. 1997;99(1):9–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Schoeffel RE, Anderson SD, Altounyan RE. Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline. Br Med J (Clin Res Ed). 1981;283(6302):1285–7.CrossRefGoogle Scholar
  18. 18.
    Gonzalez-Angulo Y, Wiysonge CS, Geldenhuys H, Hanekom W, Mahomed H, Hussey G, Hatherill M. Sputum induction for the diagnosis of pulmonary tuberculosis: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2011 [Epub ahead of print]. Available from: http://www.springerlink.com/content/er6674p5785711rg/.
  19. 19.
    Crofton J, Horne NW, Miller F. Clinical tuberculosis. London: The Macmillan Education Limited; 2008. ISBN: 140509737X.Google Scholar
  20. 20.
    Atif M, Sulaiman SAS, Shafie AA, Muttalif AR, Ali I, Saleem F. Applying patient centered approach in management of pulmonary tuberculosis: a case report from Malaysia. J Basic Clin Pharm. 2011;2(3):129–31.Google Scholar
  21. 21.
    Mason J, Reynolds R, Rao N. The systemic safety of fexofenadine HCl. Clin Exp Allergy. 1999;29(S3):163–70.Google Scholar
  22. 22.
    Mattila MJ, Paakkari I. Variations among non-sedating antihistamines: are there real differences? Eur J Clinical Pharmacol. 1999;55(2):85–93.CrossRefGoogle Scholar
  23. 23.
    Woodward JK. Pharmacology of antihistamines. J Allergy Clin Immunol. 1990;86(4):606–12.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Muhammad Atif
    • 1
    Email author
  • Syed Azhar Syed Sulaiman
    • 2
  • Asrul Akmal Shafie
    • 3
  • Irfhan Ali
    • 4
  • Mohamed Azmi Hassali
    • 3
  • Fahad Saleem
    • 3
  1. 1.Discipline of Clinical PharmacySchool of Pharmaceutical Sciences, Universiti Sains MalaysiaPenangMalaysia
  2. 2.School of Pharmaceutical SciencesUniversiti Sains MalaysiaPenangMalaysia
  3. 3.Discipline of Social and Administrative PharmacySchool of Pharmaceutical Sciences, Universiti Sains MalaysiaPenangMalaysia
  4. 4.Head of Respiratory DepartmentPenang General HospitalPenangMalaysia

Personalised recommendations